col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

AEPress, s.r.o.: Bratislava Medical Journal
  original article Date Title Authors   All Authors
1 [GO] 2021―Aug―31 The highly protective natural medical agents against COVID-19 F. Gokalp, K. Sayin
2 [GO] 2021―Aug―31 Comparison of standard prophylactic and preemptive therapeutic low molecular weight heparin treatments in hospitalized patients with COVID-19 B. Copur, S. Surme, U. Sayili, G. Tuncer, E. Zerdali, M. Yazla, et al. (+7)
3 [GO] 2021―Aug―31 Contrast-induced acute kidney injury in COVID-19 patients M. Gucun, M. E. Isik
4 [GO] 2021―Aug―31 Could Peganum harmala be effective in the treatment of COVID-19? B. Tuzun, T. Nasibova, E. Garaev, K. Sayin, H. Ataseven
5 [GO] 2021―Jul―20 Acceptance of a vaccine against COVID-19 - a systematic review of surveys conducted worldwide M. Snehota, J. Vlckova, K. Cizkova, J. Vachutka, H. Kolarova, E. Klaskova, H. Kollarova
6 [GO] 2021―Jul―20 The use of prone positioning in severe COVID-19 outside the intensive care unit M. Yildiz, F. Ozturk Ergur, M. Uzel Senel, S. Kavurgaci, A. Ozturk Health Sciences, Ankara Ataturk Chest
7 [GO] 2021―Jul―20 Evaluation of index of cardiac electrophysiological balance in COVID-19 patients R. Asoglu, H. Tibilli, E. Asoglu, N Aladag, M. Ozdemir, A. Suner
8 [GO] 2021―Jun―23 Determination of inhibitor activity of drugs against the COVID-19 M. A. Gedikli, B. Tuzun, K. Sayin, H. Ataseven
9 [GO] 2021―May―18 Can we estimate cytokine storm from initial computed tomography images of Coronavirus disease-2019 patients? C. Ozturk, O. Gungor, F. Koc, E. F. Goktas, N. Dereli, S. K. Corbacioglu, S. U. Ramadan
10 [GO] 2021―May―18 Lymphocyte/mean platelet volume ratio, a new marker; is it effective in predicting the prognosis of COVID-19 cases? S. Eraybar, M. Yuksel, H. Aygun, M. O. Ay, H. Kaya, M. Bulut
11 [GO] 2021―Apr―13 Rehabilitation and physical activity for COVID-19 patients in the post infection period D. Liska, M. Andreansky
12 [GO] 2021―Apr―13 Evaluating YouTube as a source of information on COVID-19: analysis with latent Dirichlet allocation method A. Doganer, Z. J. Zhang
13 [GO] 2021―Mar―17 Management of patients with colorectal cancer in COVID-19 pandemic hospital O. Catal, B. Ozer, M. Sit
14 [GO] 2021―Mar―17 Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent? E. Cetiner, K. Sayin, B. Tuzun, H. Ataseven
15 [GO] 2021―Feb―16 The relationship between vitamin D and the severity of COVID-19 N. Basaran, M. Adas, Y. Gokden, N. Turgut, T. Yildirmak, G. Guntas
16 [GO] 2021―Feb―16 Potential therapeutic road for targeting the SARS-CoV-2 at throat M. Kaya, A. M. Abuaisha, N. Serakinci, S. Ozturk
17 [GO] 2021―Jan―27 Clinical characteristics, maternal and neonatal outcomes of pregnant women with SARS-CoV-2 infection in Turkey M. Ozsurmeli, H. Terzi, M. Hocaoglu, R. A. Bilir, T. Gunay, D. Unsal, et al. (+2)
18 [GO] 2021―Jan―04 COVID-19 molecular level laboratory diagnoses M. Pohanka
19 [GO] 2021―Jan―04 Neurological symptoms in COVID-19 patients E. Altunisik, H. S. Sayiner, S. Aksoz, E. Cil, G. Ozgenc
20 [GO] 2020―Dec―10 Vitamin D may protect against multiple organ damage caused by COVID-19 H. Aygun
21 [GO] 2020―Dec―10 Challenges in COVID-19 diagnosis A. K. Erenler, A. Baydin
22 [GO] 2020―Dec―10 Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement R. Yilmaz, G. Adas, Z. Cukurova, K. Kart Yasar, N. Isiksacan, O. N. Oztel, E. Karaoz
23 [GO] 2020―Dec―10 Health anxiety status of elite athletes in COVID-19 social isolation period G. Ozen, H. Koc, C. Aksoy
24 [GO] 2020―Nov―09 Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19 S. Gunay, S. Caliskan, D. Sigirli, E. Sahin
25 [GO] 2020―Nov―09 Glucose-6-phosphate dehydrogenase deficiency enhances Covid-19 infection in elderly people S. M. N.
26 [GO] 2020―Nov―09 Is mitochondrial bioenergetics and coenzyme Q10 the target of a virus causing COVID-19? A. Gvozdjakova, F. Klauco, J. Kucharska, Z. Sumbalova
27 [GO] 2020―Sep―21 Dental treatment recommendations and coronavirus disease 19 (COVID-19) T. Siebert, M. Janickova, B. Stenchlakova, D. Statelova
28 [GO] 2020―Sep―21 Coronaviruses as the emerging threats for human health: should we be prepared for the future outbreaks of new coronaviruses? R. Bahrami, D. Hashemi, S. Keshavarz Aziziraftar, P. Rahimi
29 [GO] 2020―Sep―21 How do arbidol and its analogs inhibit the SARS-CoV-2? A. Aktas, B. Tuzun, A. H. Taskin, K. Sayin, H. Ataseven
30 [GO] 2020―Aug―21 The evaluation of prognostic value of acute phase reactants in the COVID-19 B. Yormaz, D. Ergun, B. Tulek, R. Ergun, K. M. Korez, M. Suerdem, F. Kanat
31 [GO] 2020―Aug―21 Flavonoids as a potential adjuvant therapy of COVID-19? T. Torkos, J. Macay
32 [GO] 2020―Aug―21 Could boron be used as coronavirus inactivation agent? F. Orak, A. Gundes, K .T. Yalcinkaya, Y. Orak
33 [GO] 2020―Jun―26 Rationale Use of Neutrophil-to-lymphocyte ratio for early diagnosis and stratification of COVID-19 R. Zahorec, I. Hulin, P. Zahorec
34 [GO] 2020―Jun―26 Few Insights on the problem of COVID-19 O. El Hassoun, Z. Valaskova, S. Polak, I. Hulin
35 [GO] 2020―Jun―26 Analysis of general surgery outpatient clinic admissions and operations during COVID-19 pandemic in Turkey: Reactions of 12728 patients S. Ferahman, A. C. Dural, H. Aydin, N. A. Sahbaz, C. Akarsu, K. D. Peker, et al. (+2)
36 [GO] 2020―Jun―26 Coronavirus pandemic and the Slovak medical faculties P. Demes, P. Traubner
37 [GO] 2020―Apr―17 Proposal for complementary targeted public health anti-epidemic measures during the pandemics of COVID-19 R. Hatala
38 [GO] 2020―Mar―30 Novel unorthodox strategies to reduce the case fatality rate of COVID-19 in high risk groups including patients using ace inhibitors Hlavaty T, Krajcovicova A


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.005 sec